MedTrace Logo

Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure

NCT01693042 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2020-02-26

No results posted yet for this study

Summary

Single or repeated application of autologous bone marrow-derived stem cells to treat chronic post-infarction heart failure

Conditions

Interventions

BIOLOGICAL

intracoronary infusion of autologous bone marrow-derived cells

Intracoronary infusion into open vessel / bypass supplying previous (\> 3 months) infarct area

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Andreas M Zeiher, MD · Cardiology, Goethe University Frankfurt

  • Birgit Assmus, MD · Cardiology, Goethe University Frankfurt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2022-11-30
Completion
2025-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01693042 on ClinicalTrials.gov